|
Teva’s Novel Oral Contraceptive Is Comparable to Competitors in Phase III
Teva’s ascending-dose, extended-regimen oral contraceptive Quartette is effective at preventing pregnancy and has a comparable safety profile to other oral birth control pills, the company said.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives